A key panel of government functionaries has stipulated plans to revamp the three-tier approach for clinical trial approvals in India, bringing significant relief to the beleaguered clinical research sector in the country.
India currently follows a layered review process for clinical trial-related approvals, under which applications are initially evaluated by specialized Subject...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?